Alpine Associates Management’s Myovant Sciences Ltd. MYOV Stock Holding History

Alpine Associates Management’s Portfolio MYOV Stock Details MYOV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q1	–	Sell	-1,307,785	Closed	-$35.3M	–	45
2022 Q4	$35.3M	Buy	+1,307,785	New	+$34.4M	1.61%	23

Other funds holding MYOV

HNB

Huntington National Bank Columbus, Ohio $20.6B AUM 34.61% 1-Year Est. Return

Alpine Associates Management's MYOV Position: Q1 2023 in Review

Alpine Associates Management sold out of Myovant Sciences Ltd. (MYOV) in Q1 2023, closing a stake of 1,307,785 shares — an estimated $35.3M sold.

Alpine Associates Management first reported a position in MYOV in Q4 2022 and held it in 1 quarter. The position peaked at $35.3M in Q4 2022. 2 funds tracked by Wall St. Rank hold MYOV as of Q1 2023.

Alpine Associates Management reported no remaining Myovant Sciences Ltd. position as of Q1 2023 after selling out during the quarter.
Alpine Associates Management sold 1,307,785 Myovant Sciences Ltd. shares in Q1 2023, an estimated $35.3M.
Alpine Associates Management first reported a position in Myovant Sciences Ltd. in Q4 2022 and held it in 1 quarter.
Alpine Associates Management's Myovant Sciences Ltd. position peaked at $35.3M in Q4 2022.
2 funds tracked by Wall St. Rank held Myovant Sciences Ltd. as of Q1 2023.

Based on Alpine Associates Management's 13F filing for Q1 2023, filed 10 May 2023.